Related Experiment Videos
Protein release from alginate matrices
1Department of Analytical Chemistry and Formulation, Immunex Corporation, 51 University Street, Seattle, WA 98101, USA
Advanced Drug Delivery Reviews
|June 6, 2000
Summary
Alginate, a natural polymer from kelp, offers a mild method for entrapping proteins and other biomolecules in gels. Its tunable properties allow controlled release, making it ideal for drug delivery systems.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery
Background:
- Conventional polymeric systems for protein delivery often involve harsh conditions, leading to biomolecule denaturation.
- Alginate, a natural polysaccharide from brown algae, presents a promising alternative due to its unique properties for biomolecule encapsulation.
Purpose of the Study:
- To review the chemistry, gelation mechanisms, and physical properties of alginate.
- To highlight alginate's applications in controlled release systems for proteins and other biomolecules.
Main Methods:
- Discussion of alginate's chemical structure (beta-D-mannuronic acid and alpha-L-guluronic acid residues).
- Explanation of ionic crosslinking via divalent cations for gelation.
- Overview of different alginate gel morphologies (matrices, beads, microbeads) and in situ gelling systems.
Main Results:
- Alginate gelation is a mild process, preserving the biological activity of encapsulated proteins, cells, and DNA.
- Alginate properties like pore size, degradation rate, and release kinetics can be controlled by selecting specific alginate types and coating agents.
- Alginate's bioadhesive nature and non-immunogenicity further enhance its utility in targeted and safe delivery applications.
Conclusions:
- Alginate is a versatile biopolymer for developing controlled release systems for biomolecules.
- Its tunable properties and mild processing make it suitable for various drug delivery applications, including mucosal and wound site delivery.
- Further research into alginate-based systems promises advancements in biopharmaceutical delivery technologies.